⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FDMT News
4D Molecular Therapeutics, Inc. Common Stock
4DMT Announces New Employment Inducement Grants
globenewswire.com
FDMT
Form 8-K
sec.gov
FDMT
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
globenewswire.com
FDMT
Form 8-K
sec.gov
FDMT
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
globenewswire.com
FDMT
4DMT Announces New Employment Inducement Grants
globenewswire.com
FDMT
4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists
globenewswire.com
FDMT
Form 8-K
sec.gov
FDMT
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
globenewswire.com
FDMT
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
globenewswire.com
FDMT
HTGC